Testosterone Levels and Breast Cancer Risk in Premenopausal Women
Author Information
Author(s): Joanne F Dorgan, Frank Z Stanczyk, Lisa L Kahle, Louise A Brinton
Primary Institution: Fox Chase Cancer Center
Hypothesis
Are premenopausal serum estradiol and testosterone levels associated with breast cancer risk?
Conclusion
Premenopausal women with elevated serum testosterone levels are at an increased risk of breast cancer.
Supporting Evidence
- Serum testosterone was significantly associated with breast cancer risk.
- Total and non-SHBG-bound estradiol were not associated with breast cancer.
- Cases had higher geometric mean testosterone concentrations than controls.
Takeaway
This study found that women who had higher testosterone levels before menopause were more likely to develop breast cancer later on.
Methodology
A prospective case-control study with 98 breast cancer cases and 168 matched controls, analyzing hormone levels using specific assays.
Potential Biases
Potential bias due to self-reported data and matching criteria relaxation.
Limitations
The study had a relatively small sample size and limited power for stratified analyses.
Participant Demographics
All participants were premenopausal women, primarily white, with an average age of 44.7 years.
Statistical Information
P-Value
0.006
Confidence Interval
95% CI, 1.6 to 10.9
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website